跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ATENZA 27 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ATENZA 27 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
ATENZA 27 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Exeltis Healthcare S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 7, 2022
Approval ID
faf0807b595436c8
Company
Exeltis Healthcare S.L.
Type
Standard
Approval Details
Approval Id
faf0807b595436c8
Drug Cima Aemps Name
ATENZA 27 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
86551
Holder Company Name
Exeltis Healthcare S.L.
Marketing Company Name
Exeltis Healthcare S.L.
Authorization Date
2022-02-07
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
27 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Psicótropos
Commercialized
Yes
Company Name
Exeltis Healthcare S.L.
Active Ingredients
METILFENIDATO HIDROCLORURO
27 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 7, 2022
Approval ID
faf0807b595436c8
Type
Standard
Back to CIMA-AEMPS Approvals
